In the first significant advancement in brachytherapy in more than 15 years, physicians at UW Medical Center have today (Oct. 26) implanted for the first time in the world a new type of radioactive ...

RICHLAND, Wash., Sept. 25, 2017 /PRNewswire/ -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment ...

RICHLAND, Wash.--(BUSINESS WIRE)-- IsoRay Inc. (AMEX: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced it will host a booth ...

CHICAGO--(BUSINESS WIRE)--Brian Moran, MD, founder and principal of the Chicago Prostate Cancer Center (CPCC) presented the results of his two-year investigation into key characteristics of Cesium-131 ...

SEATTLE, Nov. 19 (UPI) -- Washington state doctors have implanted a new and more efficient type of radioactive seeds into the body of a prostate cancer patient. The newly developed implants contain ...

LEESBURG, Fla.--(BUSINESS WIRE)--April 26, 2006--Cesium-131, a breakthrough treatment for prostate cancer, is now available to patients in the central Florida region at InterCommunity Cancer Center in ...

RICHLAND, Wash., Nov. 24, 2020 (GLOBE NEWSWIRE) -- The importance of Isoray, Inc.’s (NYSE American: ISR) Cesium-131 in treating prostate and brain cancers was underscored in multiple presentations at ...

CHICAGO, Ill. (Ivanhoe Newswire) – Every year in the United States as many as 161,000 men are diagnosed with prostate cancer. Treatments include surgery, radiation, or both. One type of radiation is ...

Every year in the United States as many as 161,000 men are diagnosed with prostate cancer. Treatments include surgery, radiation, or both. One type of radiation is brachytherapy, or the planting of ...

SEATTLE, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a precision oncology company developing alpha-particle therapies and ...